| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |